.Pharmacolibrary.Drugs.ATC.A.A10AD06 .Pharmacolibrary.Drugs.ATC.A.A10AD06| name: | InsulinDegludecAndInsulinAspart |
| ATC code: | A10AD06 | route: | subcutaneous |
| n-compartments | 2 |
Insulin degludec and insulin aspart is a fixed-ratio co-formulation of two insulin analogs used in the management of diabetes mellitus. Insulin degludec is an ultra-long-acting basal insulin and insulin aspart is a rapid-acting prandial insulin. The combination is administered subcutaneously for glycaemic control in adults with diabetes mellitus. Both agents are approved and in current clinical use.
Pharmacokinetic parameters reported for adult individuals with type 1 and type 2 diabetes; parameters typically refer to healthy adult population or diabetic adults as studied in published population pharmacokinetic analyses.